InsiderFinancial

$MRNA A Breakout Play Above $36

NASDAQ:MRNA   Moderna, Inc
$MRNA is working on a vaccine for the coronavirus. If the stock breaks out above $36, it should take off. Risk looks to be minimal. The trade should work out right away. Can do buy stop at $36. 01 and risk 20 to 50 cents, depending on your risk tolerance.

Moderna , Inc. , a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and autoimmune and cardiovascular diseases. As of February 14, 2020, the company had 12 programs in clinical trials and a total of 24 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals , Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation, as well as the Coalition for Epidemic Preparedness Innovations. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna , Inc. in August 2018. Moderna , Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Good luck to all!

To receive our alerts via email and SMS, join Insider Financial for Free at https://signup.insiderfinancial.com

We are not financial advisors. Always conduct your own research and read our full disclaimer at https://insiderfinancial.com/disclaimer/